Pretreatment factors significantly influence quality of life in cancer patients: A Radiation Therapy Oncology Group (RTOG) analysis

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 830-835

  Movsas, Benjamin ^a   Scott, Charles ^b   Watkins Bruner, Deborah ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b RTOG Headquarters   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer; Pretreatment factors; Quality of life

Indexed keywords

DIAGNOSTIC RADIOGRAPHY; HUMAN ENGINEERING; MEASUREMENT ERRORS; PATIENT MONITORING; RADIATION; SCANNING ELECTRON MICROSCOPY; TUMORS;

COLLEGE GRADUATES; KARNOFSKY PERFORMANCE STATUS; PRETREATMENT FACTORS; QUALITY OF LIFE;

HEALTH CARE;

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CAUCASIAN; CLINICAL OBSERVATION; CONTROLLED STUDY; DIVORCE; EDUCATION; EMPLOYMENT STATUS; ESOPHAGUS CANCER; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; GRADUATE; HEAD AND NECK CANCER; HISPANIC; HUMAN; INCOME; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RACE; RACE DIFFERENCE; RECTUM CANCER; SCORING SYSTEM; STANDARD; STATISTICAL SIGNIFICANCE; WIDOW;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 33646920927     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.004     Document Type: Article

References (30)

1. Movsas B. Quality of life in oncology trials. A clinical guide. Semin Radiat Oncol 13 (2003) 235-247
2. Coates A., Porzsolt F., and Osoba D. Quality of life in oncology practice. Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33 (1997) 1025-1030
3. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) Phase III Randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas. First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
4. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
5. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer. High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
6. Johnstone D.W., Byhardt R.W., Ettinger D., et al., Radiation Therapy Oncology Group. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Int J Radiat Oncol Biol Phys 54 (2002) 365-369
7. Lawton C.A., Coleman C.N., Buzydlowski J.W., et al. Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20). Int J Radiat Oncol Biol Phys 36 (1996) 673-680
8. Cella D.F., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale. Development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
9. Cella D.F. Manual for the functional assessment of cancer therapy scales, version I (1988), Rush-Presbyterian-St. Luke's Medical Center, Chicago
10. Likert R.A. A technique for the measurement of attitudes. Arch Psychol 140 (1932) 5
11. Wyrwich K., Bullinger M., Aaronson N., et al. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14 (2005) 285-295
12. Cella D.F., Eton D., Fairclough D., et al. What is Clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionaire? An analysis of date from ECOG 5592. J Clin Epidemiol 55 (2002) 286-295
13. Wyrwich K., Nienaber N., Tierney W., et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 37 (1999) 469-478
14. Wyrwich K., Tierney W., and Wolinsky F. Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52 (1999) 861-873
15. Wyrwich K., Tierney W., and Wollinsky F. Using the standard error of measurement to identify important intra-individual change on the Asthma Quality of Life Questionnaire. Qual Life Res 11 (2002) 1-7
16. Cella D.F., Hahn E.A., and Dineen K. Meaningful change in cancer-specific quality of life scores. Differences between improvement and worsening. Qual Life Res 11 (2002) 207-221
17. Jordhoy M.S., Fayers P., Loge J.H., et al. Quality of life in advanced cancer patients. The impact of sociodemographic and medical characteristics. Br J Cancer 85 (2001) 1478-1485
18. Wan G., Counte M., and Cella D.F. The influence of personal expectations on cancer patients' reports of health-related quality of life. Psycho-Oncology 6 (1997) 1-11
19. Hjermstad M., Fayers P., Bjordal K., et al. Health-related quality of life in the general Norwegian population assessed by the EORTC core Quality of Life Questionnaire-the QLQ-C30 (+3). J Clin Oncol 16 (1998) 1188-1196
20. Michelson H., Bolund C., Nilsson B., et al. Health-related quality of life measured by the EORTC QLQ-C30-reference values from a large sample of Swedish population. Acta Oncol 39 (2000) 477-484
21. Klee M., Groenvold M., and Machin D. Quality of life of Danish women; population-based norms for the EORTC QLQ-C30. Qual Life Res 6 (1997) 27-34
22. Calman K.C. Quality of life in cancer patient-An hypothesis. J Med Ethics 10 (1984) 124-127
23. Mor V., Allen S., and Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer 74 (1994) 2118-2127
24. Wan G., Counte M., Cella D.F., et al. The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients. J Outcome Measurements 3 (1999) 200-215
25. Axtell L.M., and Myers M.H. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst 60 (1978) 1209-1215
26. McWhorter W.P., Schatzkin A.G., et al. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 63 (1989) 982-987
27. Cella D.F., Orav E.J., Kornblith A.B., et al. Socioeconomic status and cancer survival. J Clin Oncol 9 (1991) 1500-1509
28. Sprangers M., and Schwartz C. The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 10 (1999) 747-749
29. O'Boyle C., McGee H., and Browne J. Measuring response shift using the schedule for evaluation of individual quality of life. In: Schwartz C., and Sprangers M. (Eds). Adaptation to changing health. Response shift in quality-of-life research (2000), American Psychological Association, Washington, DC 123-136
30. Leffall L.S. 7th biennial symposium on minorities, the medically underserved and cancer. Foreword. Cancer 91 Suppl. 1 (2001) 189-192